SR9009 (STENABOLIC) Pharmaqo

SR9009 (STENABOLIC) Pharmaqo: Overview and Applications

SR9009 (STENABOLIC) Pharmaqo is a synthetic compound derived from the Rev-ErbA ligand class. Targeted primarily at enhancing athletic performance, it is noted for its ability to significantly increase endurance while simultaneously reducing fat storage. This product is particularly popular among bodybuilders and athletes seeking a boost in physical capabilities without the adverse effects typically associated with anabolic steroids. Understanding its full potential requires a brief exploration of its components and composition.

Components and Composition of SR9009 (STENABOLIC) Pharmaqo

The effectiveness of SR9009 (STENABOLIC) Pharmaqo lies in its carefully formulated ingredients, designed to enhance performance and support metabolic health.

• Active Substance: Stenabolic.
• Raw Material: STENABOLIC.
• Chemical Name: Ethyl 3-[[[4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate.
• Formula: C20H24ClN3O4S.

This chemical composition allows SR9009 (STENABOLIC) Pharmaqo to operate effectively in the body to modulate metabolic functions, making it a preferred choice in performance enhancement scenarios.

Safety Information: Key Considerations for SR9009 (STENABOLIC) Pharmaqo

While SR9009 (STENABOLIC) Pharmaqo has demonstrated potential benefits, it is essential to acknowledge its safety profile. Users should be aware of the side effects and precautions associated with this compound.

• Side Effects: Potential alterations in circadian rhythms and limited long-term effects.
• Warnings: Not clinically approved for medical use and should be approached with caution.
• Impact on Blood Pressure: No significant impact reported in studies.

Understanding these factors is crucial for anyone considering using the product, particularly athletes who may be subject to performance-enhancing regulations.

Therapeutic Action: How SR9009 (STENABOLIC) Pharmaqo Works

The primary mechanism of action for SR9009 (STENABOLIC) Pharmaqo involves the activation of Rev-ErbA, a protein that plays a critical role in regulating metabolism. This action leads to a notable increase in mitochondrial count within muscle cells, allowing for improved energy production and endurance.

Benefits associated with SR9009 (STENABOLIC) include enhanced physical performance, decreased fat mass, and increased wakefulness. These effects are especially appealing to fitness enthusiasts and athletes who aim to optimize their training sessions. Its application as a performance-enhancing agent, however, raises important ethical considerations.

Dosage Regimen for SR9009 (STENABOLIC) Pharmaqo

For effective results, matching the dosage of SR9009 (STENABOLIC) Pharmaqo to the intended goals is critical. Although the compound is primarily used in sports, it is vital to adhere to recommended guidelines.

• Typical Dosage: Generally between 10-40 mg per day.
• Course of Treatment: Suggested duration varies depending on individual goals and prior experience with similar substances.
• Storage Conditions: Maintain at room temperature away from moisture and light.

Adhering to these dosage recommendations can help users achieve their desired outcomes while minimizing potential risks associated with inappropriate usage.